(Hatay Devlet Hastanesi, İmmünoloji ve Alerji Kliniği, Hatay, TÜRKİYE)
Ahmet KAN
(Hatay Devlet Hastanesi, Pediatrik İmmünoloji ve Alerji Kliniği, Hatay, TÜRKİYE)
Yıl: 2020Cilt: 28Sayı: 1ISSN: 2147-9291 / 2147-9291Sayfa Aralığı: 56 - 59İngilizce

90 0
Recurrent Abdominal Pain Attacks; Hereditary Angioedema
Hereditary angioedema (HAE) is an important disease characterized by recurrent episodes of angioedema without urticaria, which most often affects the skin or mucosal tissues of the upper respiratory, genitourinary and gastrointestinal tracts. The angioedema is mostly self-limited and resolves in a few days without treatment, however in some conditions such as upper respiratory involvement, may cause fatal asphyxiation. Gastrointestinal attacks are experienced by a majority of patients with HAE and can be the principal presentation. The diagnosis of hereditary angioedema may be delayed in many cases. Many patients with undiagnosed HAE may undergo inappropriate abdominal surgery. In this study, we are presenting a 14 years-old patient and his mother who are diagnosed with type 1 HAE, predominantly suffering from abdominal pain attacks due to intestinal angioedema. The patient underwent appendectomy and two times diagnostic laparotomy at different times due to unexplained abdominal pain. With this case report we wanted to raise awareness of physicians about HAE.
Dergititle.paper.fact_presentationErişime Açık
  • 1. Bork K, Meng G, staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. am J Med. 2006;119(3):267-74. [Crossref] [PubMed]
  • 2. agostoni a, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71(4):206-15. [Crossref] [PubMed]
  • 3. agostoni a, aygören-Pürsün e, Binkley Ke, Blanch a, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J allergy Clin Immunol. 2004;114(3 suppl):s51-131. [Crossref] [PubMed]
  • 4. Gompels MM, Lock RJ, abinun M, Bethune Ca, Davies G, Grathan C, et al. C1 inhibitor deficiency: consensus document. Clin exp Immunol. 2005;139(3):379-94. [Crossref] [PubMed] [PMC]
  • 5. Nzeako uC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. eur J Gastroenterol Hepatol. 2012;24(4):353-61. [Crossref] [PubMed]
  • 6. Ohsawa I, Nagamachi s, suzuki H, Honda D, sato N, Ohi H, et al. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterol. 2013;13:123. [Crossref] [PubMed] [PMC]
  • 7. Cicardi M, aberer W, Banerji a, Bas M, Bernstein Ja, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary angioedema International Working Group. allergy. 2014;69(5):602-16. [Crossref] [PubMed]
  • 8. Zuraw BL, Christiansen sC. Hereditary angioedema and bradykinin-mediated angioedema. In: adkinson NF, Bochner Bs, Burks W, Busse WW, Holgate sT, Lemanske RF, et al; eds. Middleton’s allergy: Principles and Practice, Vol 1. 8th ed. Philadelphia, Pa: elsevier/saunders; 2014. p.588-93.
  • 9. Hofman ZL, Relan a, Hack Ce. C-reactive protein levels in hereditary angioedema. Clin exp Immunol. 2014;177(1):280-6. [Crossref] [PubMed] [PMC]
  • 10. Patel N, suarez LD, Kapur s, Bielory L. Hereditary angioedema and gastrointestinal complications: an extensive review of the literature. Case Reports Immunol. 2015;2015: 925861. [PubMed]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.